XML 18 R5.htm IDEA: XBRL DOCUMENT v3.21.2
CONDENSED CONSOLIDATED STATEMENTS OF EQUITY - USD ($)
Total
Total Stockholders’ Equity
Class T and Class I Common Stock
Additional Paid-In Capital
Accumulated Deficit
Noncontrolling Interest
Beginning balance, Shares at Dec. 31, 2019     79,899,874      
Beginning balance at Dec. 31, 2019 $ 590,079,000 $ 590,079,000 $ 798,000 $ 719,894,000 $ (130,613,000) $ 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Offering costs - common stock 67,000 67,000   67,000    
Issuance of common stock under the DRIP, shares     1,643,731      
Issuance of common stock under the DRIP 15,681,000 15,681,000 $ 16,000 15,665,000    
Issuance of vested and nonvested restricted common stock 43,000 43,000   43,000    
Issuance of vested and nonvested restricted common stock, shares     22,500      
Amortization of nonvested common stock compensation 128,000 128,000   128,000    
Repurchase of common stock, shares     (578,111)      
Repurchase of common stock (5,349,000) (5,349,000) $ (5,000) (5,344,000)    
Contribution from noncontrolling interest 1,250,000         1,250,000
Adjustment to value of redeemable noncontrolling interests (530,000) (530,000)   (530,000)    
Distributions to noncontrolling interest (54,000)         (54,000)
Dividends declared (28,191,000) (28,191,000)     (28,191,000)  
Net loss [1] (13,908,000) (13,632,000)     (13,632,000) (276,000)
Ending balance, Shares at Sep. 30, 2020     80,987,994      
Ending balance at Sep. 30, 2020 559,216,000 558,296,000 $ 809,000 729,923,000 (172,436,000) 920,000
Beginning balance, Shares at Jun. 30, 2020     80,599,306      
Beginning balance at Jun. 30, 2020 569,002,000 567,955,000 $ 805,000 726,516,000 (159,366,000) 1,047,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Offering costs — common stock 5,000 5,000   5,000    
Issuance of common stock under the DRIP, shares     445,239      
Issuance of common stock under the DRIP 4,247,000 4,247,000 $ 4,000 4,243,000    
Issuance of vested and nonvested restricted common stock 29,000 29,000   29,000    
Issuance of vested and nonvested restricted common stock, shares     15,000      
Amortization of nonvested common stock compensation 44,000 44,000   44,000    
Repurchase of common stock, shares     (71,551)      
Repurchase of common stock (706,000) (706,000)   (706,000)    
Adjustment to value of redeemable noncontrolling interests (208,000) (208,000)   (208,000)    
Distributions to noncontrolling interest (22,000)         (22,000)
Dividends declared (8,150,000) (8,150,000)     (8,150,000)  
Net loss [1] (5,025,000) (4,920,000)     (4,920,000) (105,000)
Ending balance, Shares at Sep. 30, 2020     80,987,994      
Ending balance at Sep. 30, 2020 559,216,000 558,296,000 $ 809,000 729,923,000 (172,436,000) 920,000
Beginning balance, Shares at Dec. 31, 2020     81,339,337      
Beginning balance at Dec. 31, 2020 549,739,000 548,958,000 $ 813,000 733,192,000 (185,047,000) 781,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Offering costs — common stock 5,000 5,000   5,000    
Issuance of common stock under the DRIP, shares     581,491      
Issuance of common stock under the DRIP 5,499,000 5,499,000 $ 6,000 5,493,000    
Amortization of nonvested common stock compensation 105,000 105,000   105,000    
Repurchase of common stock, shares     (189,567)      
Repurchase of common stock (1,874,000) (1,874,000) $ (2,000) (1,872,000)    
Adjustment to value of redeemable noncontrolling interests (167,000) (167,000)   (167,000)    
Distributions to noncontrolling interest (62,000)         (62,000)
Dividends declared (24,435,000) (24,435,000)     (24,435,000)  
Net loss [1] (13,472,000) (13,293,000)     (13,293,000) (179,000)
Ending balance, Shares at Sep. 30, 2021     81,731,261      
Ending balance at Sep. 30, 2021 515,338,000 514,798,000 $ 817,000 736,756,000 (222,775,000) 540,000
Beginning balance, Shares at Jun. 30, 2021     81,731,261      
Beginning balance at Jun. 30, 2021 529,462,000 528,885,000 $ 817,000 736,827,000 (208,759,000) 577,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Issuance of common stock under the DRIP 0          
Amortization of nonvested common stock compensation 21,000 21,000   21,000    
Repurchase of common stock, shares     0      
Adjustment to value of redeemable noncontrolling interests (92,000) (92,000)   (92,000)    
Distributions to noncontrolling interest (7,000)         (7,000)
Dividends declared (8,239,000) (8,239,000)     (8,239,000)  
Net loss [1] (5,807,000) (5,777,000)     (5,777,000) (30,000)
Ending balance, Shares at Sep. 30, 2021     81,731,261      
Ending balance at Sep. 30, 2021 $ 515,338,000 $ 514,798,000 $ 817,000 $ 736,756,000 $ (222,775,000) $ 540,000
[1] Amount excludes $91,000 and $127,000 for the three months ended September 30, 2021 and 2020, respectively, and $310,000 and $332,000 for the nine months ended September 30, 2021 and 2020, respectively, of net loss attributable to redeemable noncontrolling interests. See Note 11, Redeemable Noncontrolling Interests, for a further discussion.